Moreover, patients in the French NAFLD cohort had higher ALT values with a median value of 57 U/L in contrast to the TS, internal VS and NASH CRN cohort that had median values ranging from 47 U/L to 49 U/L. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.